Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PRP injections for hair growth can cause temporary vision loss, which may be resolved with treatment.

PRPF is a safer and more effective treatment for hair loss than PRP.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

PRP helps with hair loss and acne scars but needs standardized preparation for consistent results.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Combining PRP with other treatments can improve hair loss outcomes.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

PRP is a promising, cost-effective treatment for hair loss by stimulating hair growth.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

Inconsistent platelet counts in PRP are due to varying blood volumes, preparation methods, and analyzer types.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

PRP therapy significantly improved hair growth in a girl with chronic alopecia areata.

The birth control pill with only progestogen can cause a false alarm in a hormone test.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.